Professor Arne Astrup, MD, DMSc. is Senior Vice President at The Novo Nordisk Foundation in Denmark, and leader of the Dept of Obesity and Nutritional Sciences. Arne Astrup has been a full professor since 1990 and Head of the Department of Nutrition, Exercise and Sports, University of Copenhagen, from 2012-20. Under Arne Astrup’s leadership the Department of Nutrition, Exercise and Sports ranked number one on the internationally recognized Shanghai Global Ranking of Sport Science Schools and Departments.
Dr Astrup is past President of World Obesity Federation and founding editor-in-chief of Obesity Reviews. He is Editor of American Journal of Clinical Nutrition. Arne Astrup’s scientific interests have been appetite regulation, treatment of obesity, type 2 diabetes, and cardiovascular disease. In 1996 Arne Astrup discovered, together with Professor Jens Holst, that GLP-1 is a satiety hormone in humans. Astrup played a major role in the prohibition in 2004 of industrially produced trans fats in foods in Denmark. Arne Astrup is one the world’s most cited scientists with frequent publications in BMJ, Lancet, Nature and New England Journal of Medicine. Arne has published more than 900 peer-reviewed papers and more than 1000 other academic publications.
Astrup was created Knight of the Order of Dannebrog in 1999 by Her Majesty Queen Margrethe II of Denmark, and Knight of the First Order of Dannebrog in November 2012. He was the recipient of the International Association for the Study of Obesity 2014 Willendorf Award.
